Bi-level vs. Single Level ESB in VATS
The Analgesic Efficacy of Bi-level Versus Single Level Erector Spinae Block in Video Assisted Thoracoscopic Surgery: a Randomized Patient Blinded Study
1 other identifier
interventional
90
1 country
1
Brief Summary
Video assisted thoracoscopic surgery (VATS) is a minimally invasive surgery to remove lesions from the thoracic cavity. It is associated with moderate pain which can lead to pulmonary complications after surgery. The Enhanced Recovery After Surgery (ERAS) and the European Society of Thoracic Surgeons recommended a multimodal analgesia approach to manage pain after VATS. Erector spinae block (ESB) is a popular analgesic block due to its ease of performance and wide coverage. It has been shown to be effective in randomized control trials. Recently, case reports on bi-level ESB are emerging, suggesting more effective analgesia compared to single level ESB. As there is no available data, the investigators are interested in conducting a randomized pilot study, comparing bi-level to single level ESB to gather baseline data for sample size calculation for a formal randomized trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2022
CompletedFirst Posted
Study publicly available on registry
March 24, 2022
CompletedStudy Start
First participant enrolled
June 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedMarch 24, 2022
March 1, 2022
7 months
January 11, 2022
March 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Opioid use in first 12 postoperaive hour
First 12 hour from arriving at postoperative recovery
Secondary Outcomes (4)
Pain score area under curve first 12 hour
First 12 hour from arriving at postoperative recovery
Pain score area under curve first 24 hour
First 24 hour from arriving at postoperative recovery
Incidence of Acute block complication - based on clinical assessment
First 12 hour since block placement
Incidence of Delayed block complication - based on clinical assessment
First 5 days
Study Arms (2)
Single level block arm - Control
ACTIVE COMPARATORSingle level erector spinae block at 4th transverse process
Bi-level block arm - Intervention
EXPERIMENTALBi-level erector spinae block at 4th and 6th transverse process
Interventions
erector spinae block at 4th and 6th transverse process
erector spinae block at 4th transverse process
Eligibility Criteria
You may qualify if:
- adult patients (at least 18 years old)
- elective unilateral wedge resection, segmentectomy, lobectomy or bilobectomy via VATS
You may not qualify if:
- history of malignant hyperthermia
- BMI \> 40, chronic pain condition
- Daily opioid consumption of more than 60 mg oral morphine equivalents
- Conversion to thoracotomy
- Insertion of epidural
- postoperative admission to ICU
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cheng Lin
London, Ontario, n6c6a7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
January 11, 2022
First Posted
March 24, 2022
Study Start
June 1, 2022
Primary Completion
January 1, 2023
Study Completion
February 1, 2023
Last Updated
March 24, 2022
Record last verified: 2022-03